Related Experiment Videos
[Clinical experience with cefuroxime in pediatric field (author's transl)]
Insights
Cefuroxime (CXM) demonstrated high clinical effectiveness in pediatric bacterial infections, successfully treating respiratory, urinary tract, and colitis cases. While generally safe, minor side effects like eosinophilia and transient liver function changes were noted in a few patients.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacokinetics
- Bacteriology
Context:
- Bacterial infections pose a significant health risk in pediatric populations.
- Cefuroxime is a broad-spectrum cephalosporin antibiotic.
- Evaluating the efficacy and safety of antibiotics in children is crucial.
Purpose:
- To assess the clinical effectiveness and safety of cefuroxime in treating pediatric bacterial infections.
- To investigate the pharmacokinetic profile of cefuroxime in pediatric patients.
- To identify potential side effects and adverse events associated with cefuroxime use.
Summary:
- Cefuroxime treatment in 11 pediatric patients with bacterial infections yielded excellent clinical results.
- Eradication of causative organisms was observed in respiratory and urinary tract infections, with bacterial count reduction in colitis.
- Minor adverse events included eosinophilia and transiently elevated liver function values in one patient.
Impact:
- Cefuroxime is a viable therapeutic option for various pediatric bacterial infections.
- Understanding cefuroxime's pharmacokinetic behavior aids in optimizing pediatric dosing regimens.
- The study highlights the generally favorable safety profile of cefuroxime in children.
Abstract:
Cefuroxime (CXM) was administered to 11 patients with pediatric bacterial infections, and clinical effective results were obtained in all these cases. Causative organisms detected in 5 cases with respiratory tract infection, and with urinary tract infections were all eliminated, and the bacterial count decreased in patients with colitis. As for side effect, 1 case developed eosinophilia, and another case with impaired liver function as underlying disease showed transitory exacerbated examination values. Time-course determinations of blood levels and urinary excretions were performed in 1 case. Fecal levels were determined in 2 cases but could not be detected; inactivation action of CXM was observed from the same fecal filtrate.